A recent Chinese study revealed that exosomal SNAP25, GAP43, neurogranin, and synaptotagmin-1, combined with APOE ε4 status, improved diagnostic accuracy (AUC = 0.88), acting as a useful biomarkers panel for the prediction of AD five to seven years before cognitive impairment. The gene discussed is SYT1; the disease is Alzheimer disease.